Frank H Netter MD, School of Medicine, Quinnipiac University, 275 Mt. Carmel Avenue, NH3-106, Hamden, CT, 06518, USA,
Curr Infect Dis Rep. 2012 Jun;14(3):246-55. doi: 10.1007/s11908-012-0256-6.
The World Health Organization coordinated a comprehensive, systematic review of the countries and areas at risk for yellow fever (YF) virus transmission. The review applied the following evidence to each country and area considered: human and non-human YF cases, human serology for anti-YF antibody obtained prior to widespread YF vaccination, altitude, vegetation, and vector distribution. The result was the categorization of countries or areas as endemic, transitional, low potential for infection, or no risk. This information was adapted to create a map that defined the areas where vaccination against YF may be recommended. Travel health professionals, countries, and public health bodies can use this information as they determine recommendations and requirements for vaccination. This paper reviews the process and outcomes of the review of YF risk, and places it in the context of providing YF vaccination.
世界卫生组织协调了对有发生黄热病（YF）病毒传播风险的国家和地区的全面、系统的审查。该审查将以下证据应用于每一个被考虑的国家和地区：人间和非人源 YF 病例、广泛开展 YF 疫苗接种之前获得的抗 YF 抗体人体血清学、海拔、植被和媒介分布。结果是将国家或地区归类为地方性、过渡性、低感染风险或无风险。这些信息被改编成一张地图，定义了可能推荐接种 YF 疫苗的地区。旅行健康专业人员、国家和公共卫生机构可以在确定接种疫苗的建议和要求时使用这些信息。本文回顾了 YF 风险审查的过程和结果，并将其置于提供 YF 疫苗接种的背景下。
